Intellectual Property Rights
The entire contents of this website, including its graphic design and underlying source files, are owned by Rosetta Genomics and protected by copyright and/or other intellectual property rights. You may download material from our web site, for your own personal, non-commercial use only. Nevertheless, you are not allowed to modify, reproduce, distribute, link into, post or transmit any material from our web site without our prior written permission. Proprietary and other legal notices or other identifying information may not be removed from any downloaded materials. Rosetta Genomics reserves all right, title and interest in and to all developments, products, services, names, marks and logos referenced in this website, whether registered or not, and nothing herein shall be construed as granting any license or right to use any name, mark or logo.
Use of Non-Personal Information
Subject to the provisions in respect of personal information, any communication or information that you may convey through our website, by email or otherwise, will be treated as non-confidential and non-proprietary information. You should have no expectation of privacy or confidentiality with respect to such information. Please do not transmit any confidential information to or through our website. Rosetta Genomics may use such communication or material for any purpose whatsoever including, but not limited to, reproduction, disclosure, transmission, publication and broadcast. You acknowledge and agree that Rosetta Genomics may use any concepts or know-how contained in any information or material you send to our website for any purpose whatsoever without payment or any compensation to you.
Use of Personal Information
Use of this website is subject to our Privacy Statement which may be accessed by clicking here.
Due to various reasons, such as technical, software, hardware or third-party vendor failures, this website may be occasionally unavailable. While Rosetta Genomics does its best to avoid such malfunctions, it cannot predict or fully control, and is not responsible for, the occurrence and duration of such malfunctions.
Rosetta Genomics will use reasonable efforts to include accurate and up-to-date information on its website, but makes no warranties or representations as to the accuracy, completeness or suitability of information presented on its website. In addition, any information presented on this website may only be accurate as of the date on which it was presented. Rosetta Genomics disclaims any responsibility to update such information. Rosetta Genomics shall not be held responsible for any action or omission taken on the grounds of any information included on its website. You hereby agree that any access and use of the website is done at your own risk. Rosetta Genomics and any party involved in developing or delivering this website shall not be liable for any direct, incidental, consequential, indirect, or punitive damage arising out of access, use, or inability to use or access this website, including, but not limited to, any damages arising from errors or omissions, misprints, out-of-date information, inaccuracies, typographical or other errors appearing on this website. In addition, Rosetta Genomics cannot guarantee that the content posted on its website has not been affected by technical malfunctions or unauthorized infiltrations. Rosetta Genomics therefore cannot and does not acknowledge that its website is free from code of contaminating or destructive purposes, such as viruses, worms, Trojan Horses, etc. We urge you to be advised with technical experts as to any measures that can be taken as precaution against such code.
Medical and Other Terms
Rosetta Genomics’ website is aimed at providing general information about Rosetta Genomics and its developments. This website does not presume to provide any investment or medical advice, including any instruction on the appropriate use of developments or products of Rosetta Genomics, its affiliates or its licensors. Users of this website should be aware that products under development described in this website have not yet been approved by any regulatory agency.
Forward Looking Statements
Various statements on this web site concerning Rosetta Genomics’ future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease, and the expected timing of submission for approval and launch of diagnostic tests using our microRNA technology, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta’s approach to discover microRNA technology and to work on the application of this technology in the development of novel diagnostics and therapeutic tools, which is unproven and may never lead to marketable products or services; Rosetta’s ability to obtain, maintain and protect its intellectual property; Rosetta’s ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta’s need and ability to obtain additional funding to support its business activities; Rosetta’s dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta’s ability to successfully develop its candidate tools, products and services; Rosetta’s ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta’s technology; competition from others using technology similar to Rosetta’s and others developing products for similar uses; Rosetta’s dependence on collaborators; and Rosetta’s short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta Genomics’ most recent Annual Report on Form 20-F as filed with the Securities and Exchange Commission.
Export of Information
The United States Export Controls laws prohibit the export of certain technical data and software to certain countries, territories and individuals. No content from this site may be downloaded or otherwise exported in violation of United States law.